Viatris gains as UBS upgrades to Buy on outlook and pipeline
Source: SeekingAlpha
2026-02-09 13:44:53 ET
More on Viatris
- 44th Annual J.P. Morgan Healthcare Conference
- Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Viatris: Looks Cheap, But Faces Continued Contraction
- Large-cap stocks with lowest dividend growth grade
- Viatris sells Biocon Biologics stake for $815 million in cash and equity deal
Read the full article on Seeking Alpha
For further details see:
Viatris gains as UBS upgrades to Buy on outlook and pipeline
Viatris Inc.
NASDAQ: VTRS
VTRS Trading
-1.46% G/L:
$14.195 Last:
2,942,277 Volume:
$14.04 Open:
VTRS Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 26, 2026 06:55:00 am
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
VTRS Stock Data
$18,451,353,349
1,140,252,173
N/A
503
N/A
Pharmaceuticals
Healthcare
US
Canonsburg
